Chemotherapy thorn PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLC

被引：2
作者：
Hendriks, Lizza E. L. [1 ]
Remon, Jordi [2 ]
Reck, Martin [3 ]
机构：
[1] Maastricht Univ, Med Ctr, GROW Sch Oncol & Dev Biol, Dept Pulm Dis, POB 5800, NL-6202 AZ Maastricht, Netherlands
[2] HM Hosp, Hosp HM Nou Delfos, Ctr Integral Oncol Clara Campal HM CIOCC, Dept Med Oncol, Barcelona, Spain
[3] German Ctr Lung Dis, LungenClin, Airway Res Ctr North, Dept Thorac Oncol, Grosshansdorf, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2022年 / 17卷 / 04期
关键词：
CELL LUNG-CANCER; ADJUVANT CHEMOTHERAPY; SINGLE-ARM; OPEN-LABEL; MULTICENTER;
D O I：
10.1016/j.jtho.2021.11.024
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：499 / 502
页数：4
相关论文
共 28 条
  • [1] Long-Term Results of the International Adjuvant Lung Cancer Trial Evaluating Adjuvant Cisplatin-Based Chemotherapy in Resected Lung Cancer
    Arriagada, Rodrigo
    Dunant, Ariane
    Pignon, Jean-Pierre
    Bergman, Bengt
    Chabowski, Mariusz
    Grunenwald, Dominique
    Kozlowski, Miroslaw
    Le Pechoux, Cecile
    Pirker, Robert
    Pinel, Maria-Izabel Sathler
    Tarayre, Michele
    Le Chevalier, Thierry
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (01) : 35 - 42
  • [2] Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
    Auperin, A.
    Le Chevalier, T.
    Le Pechoux, C.
    Pignon, J. P.
    Tribodet, H.
    Burdett, S.
    Stewart, L. A.
    Tierney, J. F.
    Stephens, R. J.
    Arriagada, R.
    Higgins, J. P.
    Johnson, D. H.
    van Meerbeeck, J.
    Parmar, M. K. B.
    Souhami, R. L.
    Bergman, B.
    Dautzenberg, B.
    Douillard, J. Y.
    Dunant, A.
    Endo, C.
    Girling, D. J.
    Imaizumi, M.
    Kato, H.
    Keller, S. M.
    Kimura, H.
    Knuuttila, A.
    Kodama, K.
    Komaki, R.
    Kris, M. G.
    Lad, T.
    Mineo, T.
    Park, J. H.
    Piantadosi, S.
    Pyrhonen, S.
    Rosell, R.
    Scagliotti, G. V.
    Seymour, L. W.
    Shepherd, F. A.
    Spiro, S. G.
    Strauss, G. M.
    Sylvester, R.
    Tada, H.
    Tanaka, F.
    Torri, V.
    Wada, H.
    Waller, D.
    Xu, G. C.
    [J]. LANCET, 2010, 375 (9722) : 1267 - 1277
  • [3] Current Panorama and Challenges for Neoadjuvant Cancer Immunotherapy
    Benitez, Jose Carlos
    Remon, Jordi
    Besse, Benjamin
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (19) : 5068 - 5077
  • [4] Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data
    Burdett, Sarah
    Rydzewska, Larysa H. M.
    Tierney, Jayne F.
    Auperin, Anne
    Le Pechoux, Cecile
    Le Chevalier, Thierry
    Pignon, Jean-Pierre
    [J]. LANCET, 2014, 383 (9928) : 1561 - 1571
  • [5] Superior efficacy of neoadjuvant compared to adjuvant immune checkpoint blockade in non-small cell lung cancer
    Cascone, Tina
    Hamdi, Haifa
    Zhang, Fahao
    Poteete, Alissa
    Li, Lerong
    Hudgens, Courtney W.
    Williams, Leila J.
    Wu, Qiuyu
    Gudikote, Jayanthi
    Peng, Weiyi
    Hwu, Patrick
    Wang, Jing
    Tetzlaff, Michael
    William, William N.
    Heymach, John V.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [6] Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)
    Cottrell, T. R.
    Thompson, E. D.
    Forde, P. M.
    Stein, J. E.
    Duffield, A. S.
    Anagnostou, V.
    Rekhtman, N.
    Anders, R. A.
    Cuda, J. D.
    Illei, P. B.
    Gabrielson, E.
    Askin, F. B.
    Niknafs, N.
    Smith, K. N.
    Velez, M. J.
    Sauters, J. L.
    Isbell, J. M.
    Jones, D. R.
    Battafarano, R. J.
    Yang, S. C.
    Danilova, L.
    Wolchok, J. D.
    Topalian, S. L.
    Velculescu, V. E.
    Pardoll, D. M.
    Brahmer, J. R.
    Hellmann, M. D.
    Chaft, J. E.
    Cimino-Mathews, A.
    Taube, J. M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (08) : 1853 - 1860
  • [7] Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands
    Cramer-van der Welle, Christine M.
    Verschueren, Marjon V.
    Tonn, Merel
    Peters, Bas J. M.
    Schramel, Franz M. N. H.
    Klungel, Olaf H.
    Groen, Harry J. M.
    van de Garde, Ewoudt M. W.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Non-Small Cell Lung Cancer, Version 2.2021 Featured Updates to the NCCN Guidelines
    Ettinger, David S.
    Wood, Douglas E.
    Aisner, Dara L.
    Akerley, Wallace
    Bauman, Jessica R.
    Bharat, Ankit
    Bruno, Debora S.
    Chang, Joe Y.
    Chirieac, Lucian R.
    D'Amico, Thomas A.
    Dilling, Thomas J.
    Dowell, Jonathan
    Gettinger, Scott
    Gubens, Matthew A.
    Hegde, Aparna
    Hennon, Mark
    Lackner, Rudy P.
    Lanuti, Michael
    Leal, Ticiana A.
    Lin, Jules
    Loo, Billy W., Jr.
    Lovly, Christine M.
    Martins, Renato G.
    Massarelli, Erminia
    Morgensztern, Daniel
    Ng, Thomas
    Otterson, Gregory A.
    Patel, Sandip P.
    Riely, Gregory J.
    Schild, Steven E.
    Shapiro, Theresa A.
    Singh, Aditi P.
    Stevenson, James
    Tam, Alda
    Yanagawa, Jane
    Yang, Stephen C.
    Gregory, Kristina M.
    Hughes, Miranda
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (03): : 254 - 266
  • [9] Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
    Felip, Enriqueta
    Altorki, Nasser
    Zhou, Caicun
    Csoszi, Tibor
    Vynnychenko, Ihor
    Goloborodko, Oleksandr
    Luft, Alexander
    Akopov, Andrey
    Martinez-Marti, Alex
    Kenmotsu, Hirotsugu
    Chen, Yuh-Min
    Chella, Antonio
    Sugawara, Shunichi
    Voong, David
    Wu, Fan
    Yi, Jing
    Deng, Yu
    McCleland, Mark
    Bennett, Elizabeth
    Gitlitz, Barbara
    Wakelee, Heather
    [J]. LANCET, 2021, 398 (10308) : 1344 - 1357
  • [10] Preoperative Chemotherapy Plus Surgery Versus Surgery Plus Adjuvant Chemotherapy Versus Surgery Alone in Early-Stage Non-Small-Cell Lung Cancer
    Felip, Enriqueta
    Rosell, Rafael
    Antonio Maestre, Jose
    Manuel Rodriguez-Paniagua, Jose
    Moran, Teresa
    Astudillo, Julio
    Alonso, Guillermo
    Manuel Borro, Jose
    Luis Gonzalez-Larriba, Jose
    Torres, Antonio
    Camps, Carlos
    Guijarro, Ricardo
    Isla, Dolores
    Aguilo, Rafael
    Alberola, Vicente
    Padilla, Jose
    Sanchez-Palencia, Abel
    Javier Sanchez, Jose
    Hermosilla, Eduardo
    Massuti, Bartomeu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (19) : 3138 - 3145
123